Publication:
Zoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.

Simple item page
dc.contributor.authorsAtahan, L.; Yildiz, F.; Cengiz, M.; Kaplan, B.; Ozkan, M.; Haydaroglu, A.; Sengoz, M.; Korcums, A. F.; Akmansu, M.; Engin, K.
dc.date.accessioned2022-03-12T15:59:40Z
dc.date.accessioned2026-01-11T13:24:43Z
dc.date.available2022-03-12T15:59:40Z
dc.date.issued2006
dc.identifier.doi10.1016/j.ijrobp.2006.07.980
dc.identifier.issn0360-3016
dc.identifier.urihttps://hdl.handle.net/11424/224473
dc.identifier.wosWOS:000241221602079
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleZoledronic acid with either standard or reduced dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized study.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS525
oaire.citation.issue3
oaire.citation.startPageS524
oaire.citation.titleINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
oaire.citation.volume66

Files

Collections

Araştırma Çıktıları